Learn & Review: Virology Lectures 2024 #2: The Infectious Cycle

Virology Course Summary: The Infectious Cycle and Virus Detection

This summary outlines the key concepts discussed in the initial lectures of a virology course, focusing on the virus infectious cycle, definitions of cell susceptibility and permissivity, methods of virus cultivation, and techniques for detecting and quantifying viruses.

I. Introduction to Virology and the Infectious Cycle

• Course Structure: The course is divided into two halves:
  • First Half (Lectures 1-12): Focuses on how viruses reproduce within cells, primarily in laboratory settings.
  • Second Half: Covers how viruses infect hosts, cause disease, and elicit immune responses.
• The Infectious Cycle: This refers to the entire series of steps a virus undergoes from its initial contact with a cell to the production of new virus particles. It is essentially virus reproduction within a cell.
• Importance of Cell Entry: A fundamental aspect of a virus's definition is its ability to enter a cell to replicate. Without cell entry, a virus cannot perform its functions.
• Simplifying Complexity: The infectious cycle is broken down into distinct steps (e.g., attachment, entry, DNA/RNA synthesis) for easier study, though these boundaries are artificial in reality.
• Precise Terminology: The course emphasizes the consistent and specific use of scientific terms.

II. Key Definitions: Cell Susceptibility and Permissivity

• Susceptible Cell:
  • Definition: A cell that possesses the specific receptor on its surface that the virus can bind to.
  • Significance: This is the first step required for viral entry.
  • Resistant Cell: A cell that lacks the necessary receptor for a particular virus.
• Permissive Cell:
  • Definition: A cell that has the internal machinery and conditions necessary to replicate the virus.
  • Significance: A cell must be both susceptible and permissive for successful viral replication.
  • Independence: Permissivity is independent of susceptibility; a cell can have a receptor but not be able to replicate the virus, or vice versa.
• Experimental Determination of Permissivity: If a cell lacks a receptor (resistant), but its genetic material (DNA or RNA) is experimentally introduced (transfection), the cell's ability to produce new virus particles indicates permissivity.
• Factors Affecting Permissivity: A cell's internal environment, including energy, transport systems, and availability of molecules like nucleotides, influences its permissivity. Differences between cell types (e.g., neuron vs. epithelial cell) can lead to varying permissivity.
• Ideal Cell for Infection: A cell that is both susceptible (has the receptor) and permissive (can replicate the virus).

III. Methods of Virus Cultivation and Study

• Historical Methods:
  • Animals: Early virology relied on inoculating animals to grow and study viruses. This method could lead to the selection of viruses with altered properties due to passage between hosts.
  • Embryonated Chicken Eggs: A significant advancement, allowing viruses to grow in various parts of the egg. Currently, primarily used for influenza virus production for vaccines.
• Modern Methods: Cell Culture:
  • Discovery: The ability to grow poliovirus in cell culture in 1949 by Enders, Weller, and Robbins revolutionized virology, making virus study much easier.
  • Cell Culture Setup: Cells are grown in dishes or flasks in a laboratory, typically forming a monolayer (a single layer of cells). They require a nutrient-rich medium, controlled temperature (37°C), and a CO2 buffer for pH stability.
  • Types of Cell Cultures:
    • Primary Cells: Derived directly from tissue (e.g., foreskin fibroblasts). They have a finite lifespan.
    • Cell Lines: Immortalized cells that can divide indefinitely. They are often abnormal (e.g., HeLa cells, which have extra chromosomes) and may not be suitable for all experiments, such as vaccine production.
    • Diploid Cell Strains: Normal cells with a diploid chromosomal content that last longer than primary cells but are not immortal.
  • Suspension Culture: For large quantities of cells, they can be grown in a spinner flask, where a magnet keeps the cells suspended.
• HeLa Cells: A famous immortal human epithelial cell line derived from Henrietta Lacks, whose cervical cancer cells were the first to be successfully immortalized. Their unique properties are linked to human papillomavirus infection.

IV. Detecting Viral Effects: Cytopathic Effect (CPE)

• Definition: Visible changes in the appearance or behavior of virus-infected cells in culture.
• Examples of CPE:
  • Rounding and Detachment: Cells lose their normal shape and detach from the surface (e.g., poliovirus infection).
  • Syncytia Formation: Infected cells fuse together to form large, multi-nucleated cells. This occurs when viral proteins on the cell surface bind to receptors on neighboring cells, mediating fusion (e.g., measles virus, SARS-CoV-2).
  • Other effects include cell lysis, inclusion body formation, and chromosomal damage.
• Significance: CPE is a crucial indicator of viral presence and can help identify the type of virus. It also demonstrates functional changes within the cell, not just visual ones.
• Application: CPE was instrumental in identifying the virus causing the COVID-19 pandemic by observing characteristic changes in cell cultures inoculated with patient samples (bronchoalveolar lavage fluid).

V. Quantifying Virus Particles: Infectivity Assays

• Challenge: Determining the number of viruses in a sample.
• Two Main Approaches:
  1. Measuring Infectivity: Assessing the virus's ability to initiate an infection.
  2. Physical Measurements: Counting virus particles or their components.
• A. Infectivity Assays:
  • Plaque Assay:
    • Principle: Developed for bacteriophages and later adapted for animal viruses. A virus suspension is added to a cell monolayer (or bacterial lawn). After incubation, areas of cell death (plaques) are counted.
    • Assumption: Each plaque originates from a single infectious virus particle.
    • Output: Measured in Plaque-Forming Units (PFU) per milliliter.
    • Agar Overlay: A semi-solid agar medium is used to restrict the diffusion of newly released viruses, preventing them from spreading too far and allowing distinct plaques to form.
    • One-Hit Kinetics: For many viruses, one infectious particle is sufficient to initiate a plaque. This is indicated by a linear relationship between virus concentration and plaque number.
    • Two-Hit Kinetics (and higher): Some viruses require multiple particles to initiate infection, resulting in a non-linear relationship.
    • Applications: Used to quantify infectious virus in stocks, patient samples (BALF, nasal swabs), and to obtain pure virus stocks (clonal isolation).
  • Endpoint Dilution Assay (TCID50):
    • Principle: Used when viruses do not form clear plaques. Serial dilutions of the virus are added to multiple wells of cells. The TCID50 (Tissue Culture Infectious Dose 50%) is the dilution at which 50% of the wells show signs of infection (CPE).
    • Application: Useful for viruses that cause CPE but not distinct plaques, and can be automated for high-throughput analysis.
• B. Physical Measurements:
  • Hemagglutination: Uses red blood cells to detect and roughly quantify virus particles that can bind to receptors on these cells (e.g., influenza virus). It's a measure of particles, not infectivity.
  • Electron Microscopy (EM): Directly visualizes and counts virus particles.
  • Enzyme Assays: Measures the activity of specific enzymes present within virus particles (e.g., reverse transcriptase in retroviruses).
  • Immunological Assays (Antigen Detection): Uses antibodies to detect viral proteins (antigens). Examples include rapid antigen tests (e.g., for COVID-19) and Western blots.
  • Nucleic Acid Detection (PCR): Amplifies specific viral DNA or RNA sequences. Important Note: PCR positivity does not necessarily indicate the presence of infectious virus, as it can detect viral fragments or non-infectious particles.
  • Sequencing: Determines the genetic makeup of viruses, allowing for phylogenetic analysis and tracking of viral evolution.
  • Green Fluorescent Protein (GFP): Can be incorporated into viruses to make them visible under fluorescence microscopy.

VI. The One-Step Growth Cycle

• Purpose: A synchronized experiment to study the replication cycle of a virus in a cell culture.
• Methodology:
  1. Adsorption: Virus is allowed to attach to cells for a set period.
  2. Dilution: The culture is diluted to stop further attachment.
  3. Incubation & Sampling: Samples are taken at various time points to measure the production of new infectious virus particles (e.g., by plaque assay).
• Key Phases:
  • Eclipse Period: The time before new infectious virus particles are detected within the cell. Viral genomes are replicating and proteins are being synthesized.
  • Latent Period: The time between the start of virus production within the cell and the release of virus into the surrounding medium.
  • Burst/Yield: The period of significant new virus particle production.
• Multiplicity of Infection (MOI): The ratio of virus particles to cells added to the culture.
  • High MOI (e.g., 5-10): Ensures most or all cells are infected, leading to a single burst of virus release and a synchronous infection.
  • Low MOI (e.g., <1): Results in some cells being uninfected, leading to multiple bursts and an asynchronous infection.
• Poisson Distribution: Mathematically describes the random distribution of viruses among cells at a given MOI.
• Distinction from Bacteria: Viral replication is significantly different from bacterial binary fission, characterized by lag phases, eclipse periods, and latent periods.

VII. Particle-to-PFU Ratio

• Definition: The ratio of the total number of physical virus particles (measured by EM or other physical methods) to the number of infectious virus particles (measured by plaque assay).
• Significance: Indicates the proportion of virus particles that are actually infectious. This ratio can vary widely among different viruses, with some having all particles infectious and others having only a small fraction.
• Reasons for Non-Infectious Particles: Defective particles, empty capsids, mutated genomes, or incomplete assembly.
• Implication: A high particle-to-PFU ratio highlights the inefficiency of virus production and the need for producing large quantities of virus to ensure sufficient infectious particles.